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Bone defectAbstract Total hip arthroplasty (THA) has progressed to be one of the most cost-effective surgical
procedures to relieve pain and restore function to the pathological hip. Ofﬁcial retrospective statistics
revealed over 500,000 cases of THA were performed per annum in the US alone, but failure cases
brought aboutmore than 40,000 revision procedures among them. The revision surgery is usually hard
to manipulate due to the formidable difﬁculty of repairing the critical bone defect. Plenty of attempts
aiming at tackling this problem have been dedicated by both tissue engineering and clinical investiga-
tors. Despite of the initial success, it is still a great challenge to overcome atypical intertrochanteric and
diaphyseal defects of proximal femur to reach a satisﬁed therapeutic outcome in terms of long-term
survivorship of the prosthesis. Given the interdisciplinary integration of biomaterial fabrication, bone
tissue engineering, rapid prototyping, and biomacromolecule/drug delivery, we propose a hypothesis
to construct a biphasic articular spacer to reach the dual goal of infection control and bone regener-
ation in this study. To be speciﬁc, this complex is consisted by a geometry-speciﬁc calcium phosphate
sheath, derived from computer aided design and low temperature 3D printing, and an axial bone
cement pillar delivering antibiotics. Theoretically, this modularized spacer possesses the potency of
enhanced osteogenesis, controlled release of speciﬁc drugs, and co-delivery of growth factors. If this
strategy is validated, further effort can be made to strengthen the printability of calcium phosphate
using the 3D printing technique, and to accelerate its translation from lab to clinics.
ª 2014 Tehran University of Medical Sciences. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Total hip arthroplasty (THA) is one of the most successful
surgical procedures performed nowadays, with excellent clini-
cal outcomes showing over 95% and 80% implant survivor-
ship at 10- and 25-year follow-up, respectively [1]. For
patients with hip problems due to a variety of conditions such
as osteoarthritis, osteonecrosis, developmental dysplasia of the
hip, and femoral neck fracture, etc., THA can relieve pain,
restore function, and improve quality of life signiﬁcantly, by
replacing or resurfacing the compromised bone and cartilage
tissue with a prosthesis mostly referred to as a ‘‘ball and
socket’’ assembly (Fig. 1a). It is estimated that more than
1 million THA are performed worldwide annually, and this
number is projected to double within the next two decades [2].
Despite of the prominent improvement, periprosthetic
infection is still an increasing and devastating complication
that results in increased morbidity, mortality, and healthcare
waste. Analysis of US Medicare data has shown a rate of peri-
prosthetic infection of 1.67% at 2 years and 0.59% at 10 years,
which is similar to the data from the European and Australian
joint registries [3]. Once periprosthetic infection occurred,
several well-established treatments are mandatory in case of
serious sequel. The vast majority of treatments include aFig. 1 Brief introduction of THA and its revision surgery. (a) The com
chronic periprosthetic infection three years after THA. Both the femora
proximal femur (red lined region). (c) All the components were removed
situ for the purpose of allowing partial motion, eliminating the infectio
reconstructed by DPF and extramedullary augmentation techniques are-operation called ‘‘revision’’ and a course of speciﬁc antibiot-
ics targeting the pathogen (mostly Staphylococcus aureus and
Staphylococcus epidermidis). The revision surgery is usually a
complete exchange of a hip replacement done in two stages:
complete removal of the implant, debridement of the infection,
and implantation of a temporary cement spacer at the ﬁrst
stage (Fig. 1b), followed by a 6-week course of intravenous
antibiotics and re-implantation of a deﬁnitive hip prosthesis
at the second stage.
One critical problem is that less host bone is usually avail-
able at the second-stage surgery, in view of multifactorial
effects of stress shielding, osteolysis, failure of the implant,
bone cement erosion, and infection (Fig. 1c). Further bone loss
may be caused by removal of the infected prosthesis during the
surgery. It was reported that diaphyseal defects of femur are
found in 13–19% of revision cases [4]. These bone defects,
especially in transtrochanteric area and the proximal diaphy-
seal of femur, can drastically impair the stability and long-term
survival of the re-implanted prosthesis (Fig. 1d).
To the best of our knowledge, although the current
antibiotic-impregnated bone cement spacer has been proved
as efﬁcient in eliminating the infection (less than 8% recur-
rence) [5], one deﬁciency during this anti-infection course is
the negligence of bone defect repair. As a matter of fact, itponents of a set of arthroplastic prostheses. (b) A case report of a
l and acetabular components failed with critical bone defect at the
at the ﬁrst stage of the revision, and a hip spacer was implanted in
n and maintaining abductor tension. (d) After 6 weeks, the hip was
t the second stage of revision.
3D-printable bioceramic hip spacer 15is very difﬁcult to regenerate the bone within defect both with
the current clinical and tissue-engineering methods, due to the
atypical volume, location, topography and geometry of the
defect cavity, and less postoperative blood supply, as well
as poor stress stimulation. Previous clinical attempts revealed
that conventional autologous bone graft exhibited poor
repair results associated with donor site morbidity, limited
availability and the risk of unpredictable resorption [6].
However, our group is still conceiving a rational way to
regenerate bone within defect by multidisciplinary and cus-
tomized approaches derived from tissue engineering (TE)
and biomaterial strategies, and this approach would result
in revolutionary advancement on the cost-effectiveness of
healthcare, the survivorship of joint prosthesis, and patients’
living expectation.
As one major form of bioceramics, calcium phosphates
(CaP), are now extensively employed as an alternative or addi-
tive to autologous bone because of their chemical similarity to
the mineral phase of bone, their superior properties of osteo-
conduction through appropriate geometry of macroporosity,
and osteoinductive potency by introducing growth factors.
Besides, exploratory studies demonstrate the promising clinical
perspective to use CaP as scaffold for musculoskeletal and
maxillofacial tissue engineering, drug delivery system and
growth factor carrier [7].
An important aspect inspiring this hypothesis is the
fast-evolvement of 3 dimensional (3D) printing. Although
inkjet-based 3D printing has been employed to fabricate
CaP scaffolds over one decade [8]. The bottleneck is that high
temperature dramatically precludes the incorporation of bio-
active molecules and drugs during the printing process. As a
latest innovation, Awad et al. recently raised a protocol of
3D printing CaP scaffolds at low temperature [9], which
holds great promise for fabricating synthetic bone graft
substitutes with enhanced performance over traditional
techniques.Hypotheses
Given the multiple limitations of the current treatment of peri-
prosthetic infection, we hypothesize that a novel biphasic
spacer, assembled by a bone defect geometry-speciﬁc calcium
phosphate sheath which is fabricated preoperatively by
patient-customized computer tomography aided design
(CAD) and low temperature 3D printing technique, and an
axial bone cement pillar ﬁtting the interior morphology of
the sheath, would be an ideal choice for the revision of the
infected arthroplasty cases combined with massive bone defect.
One important geometrical feature of this sheath is that the
external surface is designed to be micro-porous for better bone
ingrowth, and the internal surface should be smooth for the
easy removal of the cement pillar, and minimization of the
destruction to the newly-formed bone in the revision surgery.
Furthermore, the bone formation can be adjusted by introduc-
ing osteogenic molecules and factors such as bone morphoge-
netic protein (BMP), transforming growth factor (TGF), and
collagen, etc. And the anti-infection efﬁcacy can be optimized
by impregnating antibiotics within bone cement or assembling
antibiotics onto porous bioceramic surface. The proposal is
outlined schematically in Fig. 2 and reported detailedly as
the following three steps.Acquisition of bone defect data and patient-customized CAD
A helical computed tomography (CT) scan (Somatom Sensa-
tion, Siemens, Germany) is performed focusing on the affected
hip and proximal femur for an infection and bone defect co-
existing patient. To avoid the metallic artifact, the following
parameters of the CT scans are referred: 1 micrometer (mm)
in section thickness, 1 mm in intersectional distance, 140 kilo-
voltage (kV) of the tube voltage, 250 milliampere (mA) of the
tube current, 0.55 of pitch, 0 of gantry inclination, 250 of ﬁeld
of view and H70 high of ﬁlter. CT data (Digital Imaging and
Communications in Medicine, DICOM) are reconstructed
and visualized as a virtual 3D geometric model, under the
assistance of special correction softwares and iterative tech-
niques such as metal deletion technique (MDT) and gemstone
spectral imaging (GSI) [9,10]. The virtual generation can be
conducted using a mirror imaging procedure, followed by
manual post-processing and the creation of DICOM ﬁles of
the sheath [11]. The translation from DICOM into standard
tessellation language (STL) format, which is required for rapid
prototyping, can be ﬁnished using Amira software (Visage
Imaging, Germany). Finally, the virtual sheath structures are
completed and transferred to the printer using the CAD soft-
ware Think 3 Design Xpressions (think 3, USA).
Fabrication of the bioceramic sheath by 3D powder printing
The bioceramic powder, composed by hydroxyapatite and a-
tricalcium phosphate, can be prepared by solution combustion
synthesis following similar protocol presented by National
Engineering Research Center for Biomaterials of China (Sich-
uan University, Chengdu). The diluted phosphoric acid
(H3PO4) with a concentration of 8.75 wt% can be employed
as the base binder solution. While a 0.25 wt% Tween 80 (a
non-cytotoxic surfactant) and a 1.5 wt% bovine dermal type
I collagen, were respectively supplemented into the binder
formulations to optimize the viscosity and surface tension of
the binder solution, and to increase ﬂexural strength and cyto-
compatibility of the sheath.
The printing procedure can be conducted at room temper-
ature using a commercial ZPrinterª 450 (3D system, MA,
USA). Brieﬂy, the powder layer thickness is set to 90 lm and
the binder liquid/powder ratio is set as 0.48. The H3PO4 based
binder solutions are delivered by thermal inkjets to selectively
bind the powder, and the solidiﬁcation occurred by the forma-
tion of dicalcium phosphate dehydrate (Brushite) as the setting
product (Fig. 2). After printing, the structures need post-hard-
ening by immersion in 20 wt% H3PO4 for 2 · 30 seconds, and
rinse in deionized water to improve surface binding and
remove residual acidity. For cell and animal experiments, the
scaffolds can be sterilized by gamma irradiation.
Manufacture of axial bone cement pillar
Due to the brittle mechanical property of CaP, it lacks the
structural integrity necessary for stability while bone in-growth
occurs, bone cement (mostly known as polymethyl methacry-
late, PMMA) can be used to form a strong inner pillar
supporting the sheath. It should be handled and shaped
precisely by a skilled arthroplastic surgeon during the polymer-
ization. The pillar entity is composed by three parts including
Fig. 2 A schematic diagram of constructing a geometry-speciﬁc CaP sheath by computer aided design and low temperature 3D printing
technique, and its assembly with a antibiotics-delivered bone cement pillar.
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of the pillar are determined by the diameter of patient’s acetab-
ulum and tension of gluteus medius, respectively. While the
diameter and length of the stem depends on the parameters
of the sheath. Experience of the components, exothermic reac-
tion, exact mixing and handling times is quite important since
overheat would deactivate the additive drugs and growth fac-
tors delivered in the bioceramic sheath. If the bone cement pil-
lar is assembled into the CaP sheath too early, the surgeon
would encounter great difﬁculty in removing the spacer and
further destruct the new bone during revision surgery.Evaluation of the hypotheses
The following research directions are recommended to evalu-
ate our hypothesis:
(1) In vitro biomechanical tests, including three-point
bending, torture/compression strength, are required to
determine important parameters affecting the overall
mechanical performances of the spacer module (e.g.
thickness and length of the sheath).
(2) In vitro biophysicochemical tests, including scanning
microscopy, x-ray photoelectron spectroscopy, enzyme-
linked immunosorbent assay, cell adhesion and viability
assay, et al., are necessary to understand the topography
of the porous structure, the efﬁciency of incorporating
growth factor, the drug release proﬁle and
cytocompatibility.
(3) An in vivo bone healing test based on a rabbit femur
bone defect model can be established to observe the
new bone formation between host cortical bone andimplanted calcium phosphate rod, via micro-CT and
histological analysis.
Preliminary experimental data
As illustrated in Fig. 3, our group previously deﬁned the intrin-
sic topography, biocompatibility and degradability of a micro-
porous biphasic CaP scaffold (BCP), by cross-linking a novel
recombinant protein spanning the ﬁbronectin module III7–10
and extracellular domains 1 and 2 of cadherin 11 (rFN/
CDH) [12]. We found the enhanced adhesive capacity, prolif-
eration rate and osteoblastic differentiation on rFN/CDH
modiﬁed CaP through phosphotyrosine 397 of focal adhesion
Kinase. Besides, we also precisely tuned the mesenchymal stem
cell–extracellular matrix interaction on a porous BCP surface
via layer-by-layer (LbL) self-assembly of rFN/CDH, to modu-
late tissue-speciﬁc cellular responses including integrin remod-
eling and osteogenic expression proﬁle [13]. These in vitro
results were further validated by an in vivo rabbit lumbar
fusion model with the evidence of radiography and histology
at the bone-scaffold interface. These results concertedly pave
the road for this hypothesis.
Discussion
The clinical techniques aimed at addressing the problem of
bone loss have been a subject of active investigations and the
management of bone defects is one of the core elements of
the joint revision surgery. A number of methods for bone defect
reconstruction have been reported and, among them, the
impaction bone grafting (IBG), extramedullary augmentation,
Fig. 3 Preliminary experimental data supporting the current hypothesis. (a,b) The topography of a micro-porous biphasic calcium-
phosphate scaffold (BCP) was determined by scanning electron microscopy at the magniﬁcations of 100· and 3000·. (c) The rabbit
mesenchymal stem cells (BMSCs) demonstrated excellent on-growth property on the scaffold surface (shown in red arrows, at the
magniﬁcations of 100·). (d) The three-dimensional structure of the recombinant protein of ﬁbronectin/cadherin was exhibited, as well as
its key molecular motif responsible for cell adhesion. (e) The binding efﬁcacy of the protein onto the scaffold was conﬁrmed as the nitrogen
peak at 401 eV by X-ray photoelectron spectroscopy. (f) The BMSCs were labeled with Hoechst 33342 and their adhesion onto the
modiﬁed surface was signiﬁcantly increased as compared with pure BCP (100·). (g) The BMSCs exhibited enhanced osteoblastic
differentiation as evidenced by enhanced capability of matrix mineralization (shown as the red nodules, 100·). (h) Phosphotyrosine 397 of
focal adhesion Kinase, labeled as red ﬂuorescence, was proved to mediate the adhesion and differentiation of BMSCs (100·). (j) New bone
formation was detected at the peri-material area by 3D reconstructive computer tomography. (k) Continuous new bone layer bridging
host bone and BCP scaffold surfaces was observed by H.E. staining (400·).
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by a series of studies [4,14]. Brieﬂy, IBG restored the bone stock
by packing allogenous granulated bone into the defect areas
and hereby reconstructed the anatomic architecture of proxi-
mal femur. Despite the survival of the grafted bone conﬁrmed
by biopsy, IBG is accompanied by high rate of post-fracture
and prosthetic subsidence [15,16]. When combined with extra-
medullary augmentation such as metal meshes, plates, cortical
strut allografts (Fig. 1d), the IBG signiﬁcantly reduced the
strains around diaphyseal defects (up to 50% in magnitude)
[4]. Besides, long cementless stem can be stabilized by ‘‘press-
ﬁt’’ insertion of its distal end into the intact medullary cavity
of distal femur (Fig. 1d) [17], thus bypass the defects of the
proximal femur and reach DPF.
Even though, these clinical techniques largely rely on sacri-
ﬁcing the existing healthy bone or narrowing the bone defect to
achieve an initial stability. If the revision failed, there would no
more opportunity for another ‘‘re-revision’’. Thus, we concep-
tualized the original hypothesis to improve the revision success
and patient’s living quality by regenerating the lost bone and
salvaging the surrounding bone, using interdisciplinary
approaches.
The expansion of the biomaterial knowledge, and structural
and biological properties of tissue engineered scaffolds, has
greatly driven the fast evolvement of rapid prototyping (RP),
in an effort to produce pre-designed and customized TEscaffolds. Powder-based inkjet 3DP is one of the most attrac-
tive advances. It involves a sequential layering process through
which 3D porous scaffolds can be produced directly from com-
puter-generated models. In particular, low temperature 3D
printing further substantializes our hypothesis. Generally,
scaffolds manufactured from this process have the advantages
of a fully controlled geometry, customized properties and high
reproducibility [18].
In addition, our biphasic spacer module, consisted by a
bioceramic sheath and a bone cement pillar, is especially
advantageous for the following characteristics: (1) Biomechan-
ically, the gradient transition of the elastic modulus, from very
hard bone cement to less hard host bone through calcium
phosphate layer, is conﬁrmed to be in favor of osteogenesis
[19]. (2) Biochemically, many bioactive molecules and growth
factors, as well as synthesized peptides [20], aptamers [21], oli-
gonucleotides [22], etc., can be nano-assembled into the 3D
printed bioceramic system to promote osteoprogenitor and
osteoblast adhesion, proliferation and mineralization on the
material surface, thereby enhance osteointegration on the
material-host bone interface. (3) Pharmacokinetically, the 3D
printable porous structure of bioceramic sheath can also con-
tribute to the controlled release of the speciﬁc drugs to combat
infection and tumor [23,24].
In conclusion, here we raise our hypothesis that a novel
biphasic spacer module, constituted by a geometry-speciﬁc
18 Y. Zhang et al.bioceramic sheath, derived from computer aided design and
low temperature 3D printing, and an axial bone cement pillar
carrying antibiotics, would exhibit enhanced bone repair effect
for the infected arthroplasty cases combined with critical bone
defect. The implementation of our approach in the clinical
application would signiﬁcantly reduce the healthcare expense
for the joint arthroplasty surgeries, while better therapeutic
results and patients’ living quality can be expected.Overview box
1. What do we already know about the subject?
Hip revision reportedly took up to 10% of the total
THA cases in the US. The key factors hampering a suc-
cessful revision surgery are the infection control and prox-
imal bone reconstruction. Despite few preclinical
progresses proposed currently, low temperature 3D print-
ing technique holds great promise for fabricating syn-
thetic bone graft substitutes with enhanced performance.
2. What does your proposed theory add to the current
knowledge available, and what beneﬁts does it have?
It is highly achievable to fabricate a 3D printable and
patient-customized articular spacer, consisted by a micro-
porous calcium phosphate sheath and a bone cement pil-
lar, to overcome the difﬁculty in the infected arthroplasty
cases with bone defect. Delivery of speciﬁc drugs and mol-
ecules can imbue it with extra properties, which would sig-
niﬁcantly reduce the healthcare cost, the prosthetic
failure, and patients’ discommodity.
3. Among numerous available studies, what special fur-
ther study is proposed for testing the idea?
In vitro biomechanical and biophysicochemical tests
should be primarily addressed to optimize the assembly
efﬁciency of the spacer, in terms of the thickness and
porosity of the bioceramic sheath, the cytocompatibility,
and the efﬁcacy of drug loading and release proﬁle.
Conﬂict of interests
All authors report no conﬂict of interest.Acknowledgements
The authors acknowledge Myron Spector from Harvard Med-
ical School for his help in preparing the manuscript. This study
was supported by the National Natural Science Foundation of
China (Grant No. 81171720).
References
[1] Pivec R, Johnson AJ, Mears SC, Mont MA. Hip arthroplasty.
Lancet 2012;380:1768–77.
[2] Berstock JR, Blom AW, Beswick AD. A systematic review and
meta-analysis of the standard versus mini-incision posterior
approach to total hip arthroplasty. J Arthroplasty
2014;29:1970–82.
[3] Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J.
Prosthetic joint infection risk after total hip arthroplasty in the
Medicare population. J Arthroplasty 2009;24:105–9.[4] Barker R, Takahashi T, Toms A, Gregson P, Kuiper JH.
Reconstruction of femoral defects in revision hip surgery: risk of
fracture and stem migration after impaction bone grafting. J
Bone Joint Surg Br 2006;88:832–6.
[5] Fei J, Liu GD, Yu HJ, Zhou YG, Wang Y. Antibiotic-
impregnated cement spacer versus antibiotic irrigating metal
spacer for infection management after THA. Orthopedics
2011;34:172.
[6] Rosenberg AG. The use of bone graft for managing bone defects
in complex total knee arthroplasty. Am J Knee Surg
1997;10:42–8.
[7] Acarturk O, Lehmicke M, Aberman H, Toms D, Hollinger JO,
Fulmer M. Bone healing response to an injectable calcium
phosphate cement with enhanced radiopacity. J Biomed Mater
Res B Appl Biomater 2008;86:56–62.
[8] Castilho M, Moseke C, Ewald A, Gbureck U, Groll J, Pires I,
et al. Direct 3D powder printing of biphasic calcium phosphate
scaffolds for substitution of complex bone defects.
Biofabrication 2014;6:015006.
[9] Inzana JA, Olvera D, Fuller SM, Kelly JP, Graeve OA, Schwarz
EM, Awad HA, et al. 3D printing of composite calcium
phosphate and collagen scaffolds for bone regeneration.
Biomaterials 2014;35:4026–34.
[10] Boas FE, Fleischmann D. CT artifacts: causes and reduction
techniques. Imaging Med 2012;4:229–40.
[11] Barrett JF, Keat N. Artifacts in CT: recognition and avoidance.
Radiographics 2004;24:1679–91.
[12] Klammert U, Gbureck U, Vorndran E, Ro¨diger J, Meyer-
Marcotty P, Ku¨bler AC. 3D powder printed calcium phosphate
implants for reconstruction of cranial and maxillofacial defects.
J Craniomaxillofac Surg 2010;38:565–70.
[13] Zhang Y, Xiang Q, Dong S, Li C, Zhou Y. Fabrication and
characterization of a recombinant ﬁbronectin/cadherin bio-
inspired ceramic surface and its inﬂuence on adhesion and
ossiﬁcation in vitro. Acta Biomater 2010;6:776–85.
[14] Zhang Y, Li L, Zhu J, Kuang H, Dong S, Wang H, et al. In
vitro observations of self-assembled ECM-mimetic bioceramic
nanoreservoir delivering rfn/CDH to modulate osteogenesis.
Biomaterials 2012;33:7468–77.
[15] Zhang GQ, Wang Y, Chen JY, Zhou YG, Cao XT, Chai W,
et al. Management of severe femoral bone defect in revision
total hip arthroplasty – a 236 hip, 6–14-year follow-up
study. J Huazhong Univ Sci Technolog Med Sci
2013;33:606–10.
[16] Lie SA, Havelin LI, Furnes ON, et al. Failure rates for 4762
revision total hip arthroplasties in the Norwegian arthroplasty
register. J Bone Joint Surg Br 2004;86:504–9.
[17] Ornstein E, Atroshi I, Franzeb H, et al. Early complications
after one hundred and forty-four consecutive hip revisions with
impacted morselised allograft bone and cement. J Bone Joint
Surg [Am] 2002;84:1323–8.
[18] Park YS, Moon YW, Lim SJ. Revision total hip arthroplasty
using a ﬂuted and tapered modular distal ﬁxation stem with and
without extended trochanteric osteotomy. J Arthroplasty
2007;22:993–9.
[19] Zhou Z, Buchanan F, Mitchell C, Dunne N. Printability of
calcium phosphate: calcium sulfate powders for the application
of tissue engineered bone scaffolds using the 3D printing
technique. Mater Sci Eng C Mater Biol Appl 2014;38:1–10.
[20] Lindner M, Bergmann C, Telle R, Fischer H. Calcium
phosphate scaffolds mimicking the gradient architecture of
native long bones. J Biomed Mater Res A 2013;26:1–8.
[21] Zhang Y, Zhou Y, Zhu J, Dong S, Li C, Xiang Q. Effect of a
novel recombinant protein of ﬁbronectiniii7-10/cadherin 11
EC1-2 on osteoblastic adhesion and differentiation. Biosci
Biotechnol Biochem 2009;73:1999–2006.
[22] Zhu J, Huang H, Dong S, Ge L, Zhang Y. Progress in aptamer-
mediated drug delivery vehicles for cancer targeting and its
3D-printable bioceramic hip spacer 19implications in addressing chemotherapeutic challenges.
Theranostics 2014;13:931–44.
[23] Srinivasan S, Selvan ST, Archunan G, Gulyas B, Padmanabhan
P. MicroRNAs – the next generation therapeutic targets in
human diseases. Theranostics 2013;29(3):930–42.[24] Vallet-Regı´ M, Balas F, Arcos D. Mesoporous materials for
drug delivery. Angew Chem Int Ed Engl 2007;46:7548–58.
